These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15768330)

  • 21. Diagnostic yield of blood cultures from antibiotic-naïve and antibiotically treated patients with haematological malignancies and high-risk neutropenia.
    Hummel M; Warga C; Hof H; Hehlmann R; Buchheidt D
    Scand J Infect Dis; 2009; 41(9):650-5. PubMed ID: 19562624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology and treatment of infections in cancer patients.
    Maschmeyer G; Haas A
    Int J Antimicrob Agents; 2008 Mar; 31(3):193-7. PubMed ID: 17703922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance in cancer patients.
    Gudiol C; Carratalà J
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):1003-16. PubMed ID: 24834465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for Gram-negative bacterial infections in febrile neutropenia.
    Cordonnier C; Herbrecht R; Buzyn A; Leverger G; Leclercq R; Nitenberg G; Bastuji-Garin S;
    Haematologica; 2005 Aug; 90(8):1102-9. PubMed ID: 16079110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and economic burden of antimicrobial resistance.
    Maragakis LL; Perencevich EN; Cosgrove SE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.
    Bow EJ
    Curr Opin Infect Dis; 2011 Dec; 24(6):545-53. PubMed ID: 22001945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiologic study of nosocomial bacterial infection of pediatric patients at BMA Medical College and Vajira Hospital.
    Tantracheewathorn T; Vititpatarapak N; Phumisantiphong U
    J Med Assoc Thai; 2007 Feb; 90(2):258-65. PubMed ID: 17375629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
    Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM
    J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of development of antimicrobial resistance in individual patients with chronic rhinosinusitis.
    Bhattacharyya N; Kepnes LJ
    Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1201-4. PubMed ID: 15492169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A guide to antibiotic resistance in bacterial skin infections.
    Perera G; Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile].
    Rabagliati B R; Fuentes L G; Orellana U E; Oporto C J; Domínguez M I; Benítez G R; Aedo C I; Ramos G G; Garrido S M; García C P
    Rev Chilena Infectol; 2009 Apr; 26(2):106-13. PubMed ID: 19621141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.
    Cordonnier C; Buzyn A; Leverger G; Herbrecht R; Hunault M; Leclercq R; Bastuji-Garin S;
    Clin Infect Dis; 2003 Jan; 36(2):149-58. PubMed ID: 12522746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
    Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empirical therapy of infections in neutropenic patients.
    Gaya H
    Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
    [No Abstract]   [Full Text] [Related]  

  • 40. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
    Bertrand X; Costa Y; Pina P
    Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.